The number of percutaneous coronary interventions, or angioplasties, is lower in states that mandate public reporting of PCI outcomes, according to a study in the Oct. 10 issue of the Journal of the American Medical Association.
Led by Dr. Karen Joynt of the Harvard School of Public Health, Boston, researchers reviewed Medicare data for more than 100,000 patients from reporting and non-reporting states. For patients with acute myocardial infarction, their likelihood of receiving PCI in Massachusetts, Pennsylvania and New York—states with public-reporting programs— was 37.7%, compared with 42.7% in seven non-reporting states, the study said.
Read the full story at: http://bit.ly/UHpRwO
Source: Modern Healthcare
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More